CER Instituto Médico - Quilmes, Buenos Aires

Institución polivalente dedicada a la asistencia, docencia e Investigación farmacoclinica y traslacional
logoCER Instituto Médico - Quilmes, Buenos Aires
Av. Vicente Lopez 1441, Quilmes, Buenos Aires
Select an option

Specializations

Colitis ulcerosa
Enfermedad de Crohn
Lupus eritematoso sistémico

Our team

Medical staff
Edgardo Daniel Gimenez
Monica Coronel
Melina Salinger
Mariano Minos
Agostina Pontes
Graciela Betancur
Myriam Coccardo
Lorena Adriana Gonzalez
Edgardo Daniel Gimenez
Carolina Patricia Alasia
Maria Julia Papagno
Benito Jorge Velasco
Fernando Colombo Berra
Nadia Reta
Cristian Alejandro Benitez
Gustavo Cañete
Cecilia Tramontana
Cintia Schenkel

Open studies

Lupus
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) - Bristol-Myers SquibbSee more
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - POETYK SLE-2 - Bristol-Myers SquibbSee more
Ulcerative colitis
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) - LUCENT 3 - Eli Lilly and CompanySee more
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) - MK-7240-001 - Merck Sharp & Dohme LLCSee more
Cardiovascular disease
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and CompanySee more
Elevated Lipoprotein A
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and CompanySee more
Rare diseases
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome - POETYK SjS-1 - Bristol-Myers SquibbSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy